Empagliflozin vs Lovastatin

Empagliflozin vs Lovastatin: Overview

This comparison examines the pharmacological differences between Empagliflozin and Lovastatin.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Lovastatin: First naturally derived statin; prodrug hydrolyzed to active beta-hydroxy acid inhibiting HMG-CoA reductase.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Lovastatin — 2-3 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Lovastatin — C24H36O5.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Lovastatin — 404.5390 g/mol.

Type: Empagliflozin — Small molecule; Lovastatin — Small molecule.